The common belief is that as GLP-1s become more popular, that will stimulate competition in generics and new drug development. This is all good, right? However, this has not always been true. This news article provides a detailed account of the history and exorbitant pricing of the drug Revlimid, a derivative of the controversial drug thalidomide, … Read more
President Donald Trump’s second term in office has been challenging for investors, at least so far. Trump imposed sweeping tariffs on imports from most countries worldwide. For now, several industries have escaped these trade policies, including pharmaceuticals. However, recent developments suggest that it won’t last much longer. That could be bad news for leaders in … Read more
Several companies and research groups are actively exploring implantable drug delivery systems for GLP-1 receptor agonists (GLP-1 RAs), aiming to improve patient adherence, convenience, and therapeutic outcomes. Here’s a summary of key players and motivations: Getting drugs into a human body is harder than it looks. The GLP1 need to be in the blood to … Read more
UK regulators must produce clear guidelines for the prescribing and monitoring of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss, particularly when treatment is initiated online, GP leaders have urged.Representatives at the annual UK conference of local medical committees (LMCs) in Glasgow passed a motion calling for the BMA’s General Practitioners Committee UK to push … Read more
Specialist clinics set up to tackle the growing obesity epidemic in children are now routinely offering weight-loss jabs to those as young as 12. Some parents who have successfully used the injections themselves are now bringing in their overweight children for the same treatment, said Professor Carel le Roux, an obesity specialist at Imperial College London. … Read more
Watch as experts from healthcare industry investigate the popularity of GLP-1 drugs
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on mood, well-being, and quality of life in those both with and without mental illness, according to a systematic review of the available evidence being presented … Read more
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for meats or fried foods, and scientists are beginning to figure out why
WeightWatchers falls, but these alternatives are stepping up to the scale.
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.